»¶Ó­·ÃÎÊÖйúº£Ï¿¸ß¿¼ÃÅ»§ÍøÕ¾¡ª¡ª¸£½¨¸ß¿¼Íø
ÊÖ»úÕ¾ | ԺУֱͨ³µ | ×¢²áÖ¾Ô¸ÍøÕ¾Õ˺Å

¸£½¨Ò½¿Æ´óѧ

197236È˹Ø×¢
¸£½¨Ò½¿Æ´óѧ£ºÆÕͨ±¾¿Æ ¸ßУÀàÐÍ£ºÒ½¿ÆÀà
ÊÖ»ú°æ
Ìîд±íµ¥£¬
½«ÓÐÀÏʦΪÄú1v1·þÎñ
Ê×Ò³ > ԺУ¿â > ¸£½¨Ò½¿Æ´óѧ > ¸ßУÊ×Ò³
¸£½¨Ò½¿Æ´óѧ
¸£½¨Ò½¿Æ´óѧԺУ¼ò½é
¸£½¨Ò½¿Æ´óѧ´´½¨ÓÚ1937Ä꣬ÊÇÎÒ¹ú½¨Ð£½ÏÔçµÄ¹«Á¢±¾¿ÆҽѧԺУ֮һ¡£Ñ§Ð£ÊÇÒ»ËùÒÔҽΪÖ÷£¬¶àѧ¿ÆЭµ÷·¢Õ¹£¬¾ßÓÐÍêÕûÈ˲ÅÅàÑøÌåϵµÄ¸£½¨Ê¡¡°Ë«Ò»Á÷¡±½¨Éè¸ßУ£¬ÊǸ£½¨Ê¡ÎÀÉúÈ˲ÅÅàÑøÖÐÐÄ¡¢Ò½Ñ§¿ÆѧÑо¿ÖÐÐĺÍÒ½ÁÆÎÀÉú·þÎñÖÐÐÄ¡£¸ù¾ÝÈí¿Æ¡°2019ÄêÖйú×îºÃÒ½¿Æ´óѧ¡±ÅÅÃûÏÔʾ£¬ÎÒУλÁÐÈ«¹úµÚ17Ãû¡£ ѧУÏÖÓÐÉϽ֡¢Ì¨½­2¸öУÇø£¬¹æ»®Õ¼µØÔ¼1500Ķ¡£ÉèÓÐ21¸öѧԺ£¨²¿£©£¬28¸ö±¾¿Æרҵ£¬ÆäÖйú¼Ò¼¶ÌØɫרҵ4¸ö¡£ÏÖÓнÌÖ°Ò½»¤Ô±¹¤11900¶àÈË£¨º¬¸½ÊôÒ½Ôº£©£¬ÔÚУȫÈÕÖÆѧÉú16000¶àÈË¡£Ó뺣ÄÚÍâ120¶àËù¸ßУºÍ¿ÆÑÐԺУ¿ªÕ¹Á˶à²ã´Î¡¢¶à½Ç¶ÈµÄ½»Á÷ºÏ×÷¡£ ѧУ¼á³Ö°ÑÈ˲Å×÷Ϊ·¢Õ¹µÄµÚÒ»×ÊÔ´£¬ÊµÊ©¡°È˲ÅǿУ¡±Õ½ÂÔ¡£ÏÖÓÐרÈνÌʦ1583ÈË£¬ÆäÖоßÓв©Ê¿Ñ§Î»½Ìʦռ42.96%£¬½ÌÊÚ500ÈË£¬¸±½ÌÊÚ596ÈË¡£ÈëÑ¡¡°ÍòÈ˼ƻ®¡± ¡°ÐÂÊÀ¼Í°ÙǧÍòÈ˲Ź¤³Ì¡±¹ú¼Ò¼¶ÈËÑ¡¡¢¹ú¼Ò/ÎÀÉú²¿ÓÐÍ»³ö¹±Ï×ÖÐÇàÄêר¼Ò¡¢½ÌÓý²¿ÐÂÊÀ¼ÍÓÅÐãÈ˲ÅÖ§³Ö¼Æ»®ÈËÑ¡¡¢½ÌÓý²¿¹Ç¸É½ÌʦµÈ¹ú¼Ò¼¶¸ß²ã´ÎÈ˲Å41È˴Σ¬¡°Ä϶¡¸ñ¶û¡±½±Õ»ñµÃÕß2ÈË£¬ÀúÄêÏíÊܹúÎñÔºÌØÊâ½òÌùר¼Ò120ÈË£¬¹ú¼Ò¼¶½ÌѧÍŶӺÍÈ«¹ú¸ßУ»Æ´óÄêʽ½ÌʦÍŶÓ2¸ö£»¸£½¨Ê¡¡°°ÙÈ˼ƻ®¡±¡¢¸£½¨Ê¡¡°Íâר°ÙÈ˼ƻ®¡±ÈËÑ¡µÈÊ¡¼¶¸ß²ã´ÎÈ˲Å315È˴Ρ£ ѧУÒÔÈ˲ÅÅàÑøΪºËÐ ¸ü¶à>>
ԺУ»ù±¾ÐÅÏ¢
  • ѧУ´úÂ룺10392
  • ´´°ìʱ¼ä£º1937Äê
  • ÓÊÕþ±àÂ룺350122
  • ËùÊôµØÇø£º¸£½¨.¸£ÖÝ
  • ѧУÐÔÖÊ£ºÆÕͨ±¾¿Æ
  • У԰µØÖ·£º¸£½¨Ê¡¸£ÖÝÊдóѧÐÂÇøѧ¸®±±Â·1ºÅ
  • ѧУÀàÐÍ£ºÒ½¿ÆÀà
  • Ö÷¹Ü²¿ÃÅ£ºÊ¡½ÌÓýÌü
ԺУ·ÖÊýÏß
| | |
С±àÕýÔÚ¼ÈëÖÐ...

¸£½¨Ò½¿Æ´óѧԺУ¶¯Ì¬

¸ü¶à
С±àÕýÔÚ¼ÈëÖÐ...
  • ¸£½¨Ò½¿Æ´óѧ¾Ù°ìѧϰ¹á³¹¡¶Ðŷù¤×÷ÌõÀý¡·×¨Ì⸨µ¼½²×ù
    6ÔÂ20ÈÕ£¬¸£ÖÝÊеÚÊ®Èý´Î¹éÇÈÇȾì´ú±í´ó»áÔÚ¸£½¨»áÌÃÕÙ¿ª¡£´ó»áÑ¡¾Ù²úÉú¸£ÖÝÊÐÇÈÁªµÚÊ®Èý½ìίԱ»á£¬ÆÚ¼äÕÙ¿ªÊ®Èý½ìÒ»´Îȫί»á£¬Ñ¡¾Ù²úÉúÐÂÒ»½ì³£Î¯¡¢Ö÷ϯ¡¢¸±Ö÷ϯ¡¢ÃØÊ鳤¡£ÎÒУÇÈÁª³ÉÔ±ÁõÀñ±óµ±Ñ¡¸£ÖÝÊÐÇÈÁªµÚÊ®Èý½ìίԱ»á³£ÎñίԱ¡¢¼æÖ°¸±Ö÷ϯ¡£(ͳս²¿)
    07-01
  • ¸£½¨Ò½¿Æ´óѧ¸½ÊôµÚÒ»Ò½ÔºÉñ¾­ÄÚ¿ÆÍŶÓÑо¿½á¹ûÔÚ¹ú¼ÊȨÍþÔÓÖ¾·¢±í
    ½üÈÕ£¬ÎÒУ¸½ÊôµÚÒ»Ò½ÔºÉñ¾­ÄÚ¿ÆÍŶÓÂÛÎÄ¡°Expanding the phenotype and genotype spectra of PLIN4-associated myopathy with rimmed ubiquitin-positive autophagic vacuolation¡±ÔÚÉñ¾­²¡Ñ§¹ú¼ÊȨÍþÔÓÖ¾Acta NeuropathologicaÔÚÏß·¢±í¡£ÎÒУ¸½ÊôµÚÒ»Ò½ÔºÉñ¾­ÄÚ¿ÆÍõÄû½ÌÊÚΪͨÐÅ×÷Õߣ¬Íõ־ǿ½ÌÊÚΪ¹²Í¬Í¨ÐÅ×÷Õߣ¬ÎÒУ²©Ê¿Ñо¿ÉúÑ¡¢Ë¶Ê¿Ñо¿ÉúÔøÒ»ºãΪ¹²Í¬µÚÒ»×÷Õß¡£
    07-01
  • ¸£½¨Ò½¿Æ´óѧÕÙ¿ª2022Äê»ù²ã×éÖ¯½¨É蹤×÷»áÒé
    6ÔÂ21ÈÕÏÂÎ磬ÎÒУÔÚÆìɽУÇøÐÐÕþ¥ѧÊõ±¨¸æÌüÕÙ¿ª2022Äê»ù²ã×éÖ¯½¨É蹤×÷»áÒ顣УÁìµ¼³ÂÏþ´º¡¢ÍõÊ«ÖÒ¡¢»Æ°®Ãñ¡¢ÎººÍ¾ü³öϯ»áÒ顣Уµ³Î¯Êé¼Ç³ÂÏþ´º×÷×ܽὲ»°£¬Ð£µ³Î¯¸±Êé¼ÇÍõÊ«ÖÒ×÷¹¤×÷±¨¸æ£¬Ð£µ³Î¯¸±Êé¼Ç»Æ°®ÃñÖ÷³Ö»áÒé¡£
    07-01
  • ¸£½¨Ò½¿Æ´óѧ¾Ù°ì2022ÄêУ½ÌÖ°¹¤Æ¹ÅÒÇò±ÈÈü
    6ÔÂ18ÈÕ£¬Ð£Ìåί¡¢Ð£¹¤»áÔÚÉϽÖУÇø×ÛºÏÌåÓý¹Ý¾Ù°ìÁË2022ÄêУ½ÌÖ°¹¤Æ¹ÅÒÇò±ÈÈü£¬À´×ÔУ±¾²¿¼°¸½ÊôÒ½ÔºµÄ9Ö§´ú±í¶Ó½ü100È˲μÓÁ˴˴αÈÈü¡£
    07-01
  • ¸£½¨Ò½¿Æ´óѧͳһսÏ߸°ÕþºÍÏØ¿ªÕ¹¡°Ï²Ó­¶þÊ®´ó ͬÐÄÆ×ÐÂƪ¡±Ö÷Ìâ»î¶¯
    6ÔÂ25ÈÕ-26ÈÕ£¬Ð£µ³Î¯Í³Õ½²¿´øÁìÖ¹«µ³Ò½´óίԱ»á²¿·Öµ³Ô±¸°ÕþºÍÏØ¿ªÕ¹¡°Ï²Ó­¶þÊ®´ó ͬÐÄÆ×ÐÂƪ¡±Í¬ÐÄ»¤½¡¿µÒ½ÁÆ·þÎñ»î¶¯¡£Ö¹«µ³Ò½ÁÆר¼ÒÔÚÕþºÍÏØÒ½Ôº·Ö±ð×ö¡°ÄÔ×äÖÐÈçºÎʶ±ð¡±¡°Ò©ÎïÐÔ¸ÎËðÉ˵Ļù²ãÖ¸ÄÏ¡±¡°Î£Öز¡È˾«×¼Á¬ÐøÉöÌæ´úÖÎÁÆ¡±×¨Ìâ½²×ù£¬Îª×ÜÒ½Ôº¸÷³ÉÔ±µ¥Î»Ò½Ê¦´«ÊÚÁÙ´²ÕïÁÆ֪ʶ¡£Ò½ÁÆר¼Òð×Å¿áÊʯÍÍÕòÎ÷½òî´×å´å¿ªÕ¹ÒåÕï»î¶¯£¬Îª´åÃñÌṩÓÅÖÊÒ½ÁÆ·þÎñ¡£Í¬Ê±£¬Í³Õ½²¿Ò»Ðл¹ÁªºÏÉç»áÁ¦Á¿ÎªÏØ×ÜÒ½ÔººÍÎ÷½òî´×å´åί»á¾èÔù¼ÛÖµ15ÍòÔªµÄÒ½ÁÆÉ豸¡£
    07-01
У԰·ç¹â
¸ü¶à
С±àÕýÔÚ¼ÈëÖÐ...
ÔÚÏß±¨Ãû
  • ±¨ÃûԺУ£º
  • רҵѡÔñ£º
  • ѧÉúÐÕÃû£º
  • ÁªÏµ·½Ê½£º
  • ³öÉúÄêÔ£º
  • »§¼®Ê¡ÊУº
  • ΢ÐÅ/QQ£º
  • ±¸×¢ÐÅÏ¢£º
  • ѧÉúÐÔ±ð£º
    ÄÐÅ®
ÈÈÃÅԺУ

Copyright © 2008-2022 ¸£½¨±±¿ÆÐÅÏ¢¼¼ÊõÓÐÏÞ¹«Ë¾°æȨËùÓÐ

ÍøÕ¾±¸°¸ºÅ£ºÃöICP±¸11026331ºÅ-1

¸ß¿¼ÕÐÉú/¸ß¿¼×Éѯµç»°£º4000-360-980

Õ˺ÅÃÜÂëµÇ¼

×¢²á
ÆäËûµÇ¼·½Ê½